PCN101 A Cost-Effectiveness Analysis for Second-Line Treatment of Relapsed/Refractory (RR) Multiple Myeloma (MM) in the United Kingdom
Abstract
Authors
Y. Jiang M. Spencer A. Gauthier M. Pacou
Y. Jiang M. Spencer A. Gauthier M. Pacou
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now